Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karthik Ramasamy

Showing results (1-10 of 165) with videos related to

Pageof 17
Sort By:
The Lancet. Oncology|November 1, 2019
Reducing infection-related morbidity and mortality in patients with myelomaKarthik Ramasamy
Expert Opinion on Investigational Drugs|March 19, 2011
Pomalidomide therapy for myelomaStephen Schey, Karthik Ramasamy
Blood|February 9, 2023
Flicking the switch in myeloma MRDEdmund Watson, Karthik Ramasamy
Clinical Lymphoma, Myeloma & Leukemia|April 26, 2020
Evolving Role of Daratumumab: From Backbencher to Frontline AgentAnkur Jain, Karthik Ramasamy
Clinical Lymphoma, Myeloma & Leukemia|July 13, 2020
Time to Redefine Risk-Stratification and Response Criteria in Immunoglobulin Light Chain Amyloidosis?Ankur Jain, Karthik Ramasamy
Blood Cells, Molecules & Diseases|August 4, 2020
Potential 'significance' of monoclonal gammopathy of 'undetermined significance' during COVID-19 pandemicAnkur Jain, Karthik Ramasamy
Reumatologia|July 18, 2025
Castleman diseaseJanine Qasim, Karthik Ramasamy
Nanoscale Advances|September 22, 2022
Multinary copper-based chalcogenide nanocrystal systems from the perspective of device applicationsSoubantika Palchoudhury, Karthik Ramasamy, Arunava Gupta
European Journal of Haematology|May 27, 2022
Generic Lenalidomide: An opportunity to address the balance of administrative burden and drug safetyHannah Patrick, Karthik Ramasamy, Sabia Rashid
Chemical Communications (Cambridge, England)|April 26, 2012
Routes to copper zinc tin sulfide Cu2ZnSnS4 a potential material for solar cellsKarthik Ramasamy, Mohammad A Malik, Paul O'Brien
Pageof 17

Showing results (1-10 of 165) with videos related to

Sort By:
Pageof 17
The Lancet. Oncology|November 1, 2019
Reducing infection-related morbidity and mortality in patients with myelomaKarthik Ramasamy
Expert Opinion on Investigational Drugs|March 19, 2011
Pomalidomide therapy for myelomaStephen Schey, Karthik Ramasamy
Blood|February 9, 2023
Flicking the switch in myeloma MRDEdmund Watson, Karthik Ramasamy
Clinical Lymphoma, Myeloma & Leukemia|April 26, 2020
Evolving Role of Daratumumab: From Backbencher to Frontline AgentAnkur Jain, Karthik Ramasamy
Clinical Lymphoma, Myeloma & Leukemia|July 13, 2020
Time to Redefine Risk-Stratification and Response Criteria in Immunoglobulin Light Chain Amyloidosis?Ankur Jain, Karthik Ramasamy
Blood Cells, Molecules & Diseases|August 4, 2020
Potential 'significance' of monoclonal gammopathy of 'undetermined significance' during COVID-19 pandemicAnkur Jain, Karthik Ramasamy
Reumatologia|July 18, 2025
Castleman diseaseJanine Qasim, Karthik Ramasamy
Nanoscale Advances|September 22, 2022
Multinary copper-based chalcogenide nanocrystal systems from the perspective of device applicationsSoubantika Palchoudhury, Karthik Ramasamy, Arunava Gupta
European Journal of Haematology|May 27, 2022
Generic Lenalidomide: An opportunity to address the balance of administrative burden and drug safetyHannah Patrick, Karthik Ramasamy, Sabia Rashid
Chemical Communications (Cambridge, England)|April 26, 2012
Routes to copper zinc tin sulfide Cu2ZnSnS4 a potential material for solar cellsKarthik Ramasamy, Mohammad A Malik, Paul O'Brien
Pageof 17